Body size and risk of differentiated thyroid carcinomas: Findings from the EPIC study
Main Authors: | Rinaldi, S, Lise, M, Clavel-Chapelon, F, Boutron-Ruault, M, Guillas, G, Overvad, K, Tjonneland, A, Halkjaer, J, Lukanova, A, Kaaks, R, Bergmann, M, Boeing, H, Trichopoulou, A, Zylis, D, Valanou, E, Palli, D, Agnoli, C, Tumino, R, Polidoro, S, Mattiello, A, Bueno-de-Mesquita, H, Peeters, P, Weiderpass, E, Lund, E, Skeie, G |
---|---|
Formato: | Journal article |
Publicado em: |
2012
|
Registos relacionados
-
Body size and risk of differentiated thyroid carcinomas: findings from the EPIC study.
Por: Rinaldi, S, et al.
Publicado em: (2012) -
Thyroid-stimulating hormone, thyroglobulin, and thyroid hormones and risk of differentiated thyroid carcinoma: the EPIC study.
Por: Rinaldi, S, et al.
Publicado em: (2014) -
Plasma cotinine levels and pancreatic cancer in the EPIC cohort study
Por: Leenders, M, et al.
Publicado em: (2011) -
Plasma cotinine levels and pancreatic cancer in the EPIC cohort study.
Por: Leenders, M, et al.
Publicado em: (2012) -
The associations of advanced glycation end products and its soluble receptor with pancreatic cancer risk: a case-control study within the prospective EPIC Cohort.
Por: Grote, V, et al.
Publicado em: (2012)